The Copper Peptide GHK-Cu market research report provides major growth drivers, restraining factors, opportunities, and potential challenges of the global market. It includes an in-depth assessment of the latest technology trends, competitive landscape, mergers & acquisitions, and other strategic developments. The report also offers a comprehensive analysis of the key players involved in the Copper Peptide GHK-Cu industry along with their strategies.
Glycyl-L-histidyl-L-lysine-copper (GHK) is a naturally occurring protein fragment found in human plasma, saliva and urine, where it exists in a complex with copper 2+. It plays a number of roles in the body encouraging wound healing, attracting immune cells, serving as an antioxidant and anti-inflammatory, stimulating glycosaminoglycan production in skin fibroblasts, and improving blood vessel development.
In a 12-week facial study, women with dry skin treated with GHK cream applied twice daily showed improved aged skin appearance, increased thickness and reduced wrinkles, while skin biopsies from the treated areas indicated strong dermal keratinocyte proliferation. GHK also stimulates nerve outgrowth in skin, which helps restore the skin’s innervation and enables it to feel touch.
Several studies have also shown that GHK enhances the ability of lung tissue to repair itself and reduces inflammatory cell infiltration in patients with Acute Lung Injury (ALI) and Chronic Obstructive Pulmonary Disease (COPD). Additionally, it has been found to attenuate LPS-induced lung histological changes and decrease TNF-alpha and IL-6 in alveolar fluid of smokers. These results suggest that GHK could be incorporated into a humidifier or inhaler to improve lung health and prevent oxidative damage and inflammation, thus promoting lung regeneration.